Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1777-1790
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1777
Table 3 Multivariate regression analysis of outcomes for patients hospitalized for Clostridioides difficile infection with coexisting nonalcoholic fatty liver disease vs viral liver disease
Outcomes
CDI with NAFLD
CDI with VLD
Unadjusted ratio (95%CI)
P value
Adjusted ratio1 (95%CI)
P value
n (weighted)
7239
11857
Hospital mortality59 (0.8%)186 (1.6%)1.94 (1.44, 2.6)< 0.00011.87 (0.95, 3.7)0.071
Acute kidney injury938 (13%)2035 (17.2%)1.39 (1.28, 1.51)< 0.00011.35 (1.1, 1.67)0.0041
Respiratory failure192 (2.7%)504 (4.2%)1.63 (1.37, 1.92)< 0.00011.83 (1.22, 2.76)0.0036
Septic shock39 (0.5%)115 (1%)1.8 (1.25, 2.59)0.00151.64 (0.67, 4.02)0.27
Intestinal perforation--0.3 (0.1, 0.89)0.030.12 (0.03, 0.57)0.0075
Intestinal obstruction331 (4.6%)527 (4.4%)0.97 (0.84, 1.12)0.670.94 (0.66, 1.33)0.725
Peritonitis61 (0.8%)106 (0.9%)1.06 (0.77, 1.45)0.710.72 (0.35, 1.52)0.39
Colectomy45 (0.6%)105 (0.9%)1.43 (1.01, 2.03)0.0441.38 (0.6, 3.15)0.44
Ileostomy-41 (0.3%) 2.47 (1.24, 4.92)0.012.62 (0.66, 10.41)0.17
LOS (days)5.75 ± 0.166.77 ± 0.151.11 (1.06, 1.16)< 0.00011.12 (1.06, 1.18)< 0.0001
Total hospitalizationcharges (dollars)38150.34 ± 1757.0146326.72 ± 1809.821.14 (1.07, 1.2)< 0.00011.13 (1.06, 1.2)< 0.0001